IONS Dividend History - Ionis Pharmaceuticals
Track the latest IONS dividend history: 0.00% Dividend Yield, 0.00% Annual Growth - Explore IONS's complete dividend history
Yield 12m
-
Cash Amount 12m
-
Dividend Growth 5y avg
-
Dividend Rating
0.19%
Yield on Cost 5y
-
Payout Ratio
-
Payout Frequency 12m
-
Payout Consistency
0.6%
Total Return 12m: -25.75%
#2 in Group
Total Return 5y: -43.40%
#1 in Group
Dividends Cash Amount per Share Yearly
Number of Payouts Yearly
5 Years Chart with Price and Dividend Yield
Top Dividend Payers in Biotechnology
People also watch
IONS Dividend History - Last 7 Dividends (Paid in USD)
| Ex-Date | Record Date | Payment Date | Period | Cash Amount | Growth Rate | Payout Yield |
|---|---|---|---|---|---|---|
| 2000-02-17 | 0.11 | |||||
| 1999-12-21 | 0.11 | |||||
| 1999-08-20 | 0.11 | |||||
| 1999-07-21 | 0.11 | |||||
| 1999-06-21 | 0.11 | |||||
| 1999-03-22 | 0.11 | |||||
| 1999-02-17 | 0.11 |
IONS Dividend History - FAQ
Does IONS pay dividends?
No, as of February 2025 IONS does not pay a dividend.What is the Dividend Yield of IONS?
As of February 2025, IONS`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of USD by the current share price of 32.32.How often does IONS pay dividends?
Over the last 12 months (TTM), IONS has issued 0 dividend payments.What is the next Ex-Dividend Date for IONS?
The next ex-dividend date for Ionis Pharmaceuticals (IONS) is unknown.What is the Dividend Growth Rate of IONS?
IONS's average dividend growth rate over the past 5 years is 0.00% per year.
Weak growth: Dividend increases are lagging behind inflation.
What is the Yield on Cost of IONS?
IONS's 5-Year Yield on Cost is %. This represents the effective dividend yield for an investor who bought Ionis Pharmaceuticals five years ago. It is calculated as the trailing 12-month dividend cash amount () divided by the purchase price five years ago (57.10):What is the Payout Consistency of IONS?
IONS Payout Consistency is 0.6%.
Highly unstable: Ionis Pharmaceuticals has a poor track record of consistent dividend payments.